Cargando...
Why Doesn’t Primary Biliary Cholangitis Respond to Immunosuppressive Medications?
PURPOSE OF REVIEW: The purpose of this review is to discuss reasons why immunosuppressive therapy so far failed in Primary Biliry Cholangitis. RECENT FINDINGS: Even targeted immunosuppressive therapy seems ineffective or potentially harmful. SUMMARY: Bile acid-mediated cholangiocyte damage, facilita...
Gardado en:
| Publicado en: | Curr Hepatol Rep |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer US
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5486599/ https://ncbi.nlm.nih.gov/pubmed/28706773 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11901-017-0345-y |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|